Forum Health Launches Revolutionary PNOĒ Metabolic Device Transforming Weight Management, Fitness and Longevity

October 1, 2024 11:15 AM

Forum Health, a premier provider of personalized integrative and functional medicine, announces the launch of the PNOĒ metabolic analysis device, offering precise insights into metabolic, heart, lung, and cellular health for personalized wellness.Now available in Forum Health's Madison and Fond du Lac, Wisconsin clinics, the PNOĒ uses a data-driven approach to weight management, fitness, and longevity optimization.Schedule a PNOĒ assessment...

Read more

'Baby Boxes' Safe Haven Baby Boxes Series Release Seven New Episodes, Bringing More Unscripted Real-Life Drama in an All-New Reality Series

October 1, 2024 11:00 AM

WOODBURN, IN / ACCESSWIRE / October 1, 2024 / Safe Haven Baby Boxes is excited to announce the release of seven all-new episodes of their highly acclaimed unscripted reality series, "Baby Boxes." The celebrated reality series has captivated audiences and the upcoming installments promise to be even more impactful, featuring dramatic rescues, heartfelt stories, and an in-depth look into the labor of individuals and organizations dedicated to...

Read more

How Can We Change Chemistry Education to Enable Industry Innovation?

October 1, 2024 11:00 AM

Authored by: Karen Madden, Chief Technology Officer, the Life Science business of Merck KGaA, Darmstadt, Germany, and Dr. Amy Cannon, Co-Founder and Executive Director, Beyond BenignNORTHAMPTON, MA / ACCESSWIRE / October 1, 2024 / Chemistry is integral to life as we know it. It has been formally studied and taught for hundreds of years. Against this timeline, green chemistry is a relatively new concept. It became part of the lexicon following...

Read more

OccuPro Launches POET 4.0: Revolutionary Upgrade to Post Offer Employment Testing Software

October 1, 2024 10:00 AM

KENOSHA, WI / ACCESSWIRE / October 1, 2024 / OccuPro, a leader in employment testing software, proudly announces the release of POET 4.0, the latest and most advanced version of its Post Offer Employment Testing (POET) software. Designed to streamline the testing process, enhance efficiency, and improve the user experience, POET 4.0 is set to revolutionize how clinics and employers handle employment testing and job analysis.Job Demands...

Read more

Black Book IT Leader Survey Reveals 8 Technologies Draining Value From Health Systems

October 1, 2024 10:00 AM

Over 900 healthcare technology experts identified key data systems that fail to deliver ROI and siphon funds from providers after implementation. In 2024, U.S. respondents reported that compounding inefficiencies, system downtimes, and ineffective health IT integration have driven total industry losses to over $8 billion annually, a sharp increase from $1.7 billion in 2017.CHICAGO, IL / ACCESSWIRE / October 1, 2024 / A new survey from Black Book...

Read more

Recovery Springs Launches Initiative to Encourage Seeking Help for Addiction

October 1, 2024 9:50 AM

Recovery Springs, an addiction treatment center, is at the forefront of efforts to challenge the stigma surrounding addiction. Through compassionate care and community outreach, Recovery Springs is dedicated to creating an environment where individuals feel empowered to seek the help they need without fear of judgment or shame.Breaking the Stigma Surrounding AddictionFor many individuals struggling with addiction, stigma remains a powerful...

Read more

Ascelia Pharma Announces Acceptance of Orviglance SPARKLE Study Primary Results as Oral Presentation in Cutting-Edge Research at the 2024 RSNA Annual Meeting

October 1, 2024 9:45 AM

Ascelia Pharma AB (publ) (STO:ACE) today announced that the primary results from the Orviglance® phase 3 SPARKLE Study have been accepted as an oral presentation at the world's largest radiology conference, RSNA. The conference will be held December 1-5 in Chicago.The SPARKLE Study evaluates the safety and efficacy of Orviglance in patients with suspected or known liver lesions and severe kidney impairment. The results, originally announced in...

Read more

New Report: Investment in Alzheimer’s Research Today Will Yield Health Benefits for the Next Generation of Adults With Down Syndrome

October 1, 2024 9:30 AM

WASHINGTON, DC / ACCESSWIRE / October 1, 2024 / Boosting research investment into the health and wellbeing of adults with Down syndrome would improve quality-of-life outcomes, reduce the costs of caregiving, and extend lifespans by five years, according to a RAND report commissioned by LuMind IDSC Foundation, the Alliance for Aging Research, BrightFocus Foundation, and the National Down Syndrome Society.Over the past 50 years, the percentage of...

Read more

Lexaria Appoints Michael Shankman as Chief Financial Officer

October 1, 2024 9:25 AM

KELOWNA, BC / ACCESSWIRE / October 1, 2024 / Lexaria Bioscience Corp. (NASDAQ:LEXX) & (NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms announces the appointment of Michael Shankman, CPA, as Chief Financial Officer (CFO) effective immediately. As a member of the executive leadership team, Mr. Shankman will lead the Company's financial operations."Mike is an accomplished individual who brings a wealth of...

Read more

KindlyMD(TM) to Participate in Upcoming October Conferences

October 1, 2024 9:00 AM

SALT LAKE CITY, UT / ACCESSWIRE / October 1, 2024 / KindlyMD, Inc. ("KindlyMD" or the "Company") (NASDAQ:KDLY), a patient-first healthcare and healthcare data company uniquely integrating traditional primary care and pain management strategies with integrated behavioral and alternative therapies, today announced that KindlyMD's CEO, Tim Pickett, is scheduled to participate in the following October 2024 investor conferences.Benzinga Cannabis...

Read more

Laxxon Medical and Adare Pharma Solutions Announce Joint Cooperation for Production of cGMP 3D Printed Oral Dosage Forms in Europe and US

October 1, 2024 9:00 AM

Laxxon Medical, a leading pharma-technology company pioneering a new generation of advanced oral drug delivery systems, and Adare Pharma Solutions, a global technology-driven CDMO focused on oral dosage forms, today announced a strategic partnership which enables the cGMP production of Laxxon's innovative 3D screen-printed drug delivery systems at Adare's cGMP-certified facilities.The partnership leverages Adare's global development and...

Read more

Innovations in Physiotherapy: Exploring New Technologies and Techniques That Improve Patient Outcomes

October 1, 2024 8:30 AM

DUBAI, UAE / ACCESSWIRE / October 1, 2024 / Patient outcomes are being revolutionized by cutting-edge technologies and advanced physiotherapy techniques. In the UAE, at Physiowell Chiropractic & Physiotherapy clinic, a fusion of robotics, AI, wearable tech and virtual solutions is embraced to boost recovery rates. These innovations in physiotherapy not only reshape treatment but also set new benchmarks for efficiency and efficacy in patient...

Read more

Jaguar Health Reports Statistically Significant Improvement in Breast Cancer Patients in its Phase 3 OnTarget Trial for its Cancer Supportive Care Drug Crofelemer

October 1, 2024 8:30 AM

Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar") today announced that the recently completed analysis of the prespecified subgroup of adult patients with breast cancer from the company's Phase 3 OnTarget trial indicate that crofelemer achieved statistical significance in this subgroup. Patients with breast cancer accounted for nearly 180 of the 287 participants in this unprecedented prophylactic clinical trial recently conducted by Jaguar family...

Read more

CBD Life Sciences Inc. (CBDL) Targets Amazon Marketplace for Strategic Business Enhancements

October 1, 2024 8:00 AM

With Amazon's market value increasing by more than $400 billion in 2024, CBD Life Sciences Inc. is poised for new revenue growth with top-selling CBD Pain Relief Roll-On and Pet Treats.SCOTTSDALE, AZ / ACCESSWIRE / October 1, 2024 / CBD Life Sciences Inc. (OTC PINK:CBDL), a fast-growing leader in the CBD industry, is excited to announce its application to list on Amazon Marketplace. Following its successful launch on Walmart Marketplace, this...

Read more

Aytu BioPharma Announces Exclusive Agreement with Lupin Pharma Canada Ltd to Commercialize Adzenys XR-ODT(R) and Cotempla XR-ODT(R) in Canada

October 1, 2024 8:00 AM

Aytu BioPharma, Inc. (the "Company" or "Aytu") (Nasdaq:AYTU), a pharmaceutical company focused on commercializing novel therapeutics, and Lupin Pharma Canada Ltd ("Lupin"), a subsidiary of global pharma major Lupin Limited, today announced the signing of an exclusive collaboration, distribution and supply agreement for Aytu's Adzenys XR-ODT® and Cotempla XR-ODT® product lines in Canada.Adzenys XR-ODT extended-release orally disintegrating...

Read more

The Rush for Non-Addictive Painkillers to Counter the Opioid Crisis Puts Two Companies Close to FDA Decisions

October 1, 2024 7:30 AM

This post was written and published as a collaboration between the in-house editorial team at Benzinga and Tonix Pharmaceuticals Holding Corp. with financial support from Tonix. The two organizations work to ensure that any and all information contained within is true and accurate as of the date hereof to the best of their knowledge and research. This content is for informational purposes only and not intended to be investing advice.CHATHAM, NJ...

Read more

Interactive Strength Inc. (Nasdaq: TRNR) to Exhibit Both CLMBR and FORME at MEFIT Health and Fitness Summit in Dubai October 3-5

October 1, 2024 7:00 AM

Interactive Strength Inc. (NASDAQ:TRNR) ("TRNR" or "the Company"), maker of innovative specialty fitness equipment under the CLMBR and FORME brands, today announced that both of the Company's brands (CLMBR and FORME) will be exhibited at the MEFIT Health and Fitness Summit in Dubai on October 3-5.MEFIT Health and Fitness Summit is in its 21st year and is the annual gathering for Gulf region health and fitness leaders to discover the latest...

Read more

Spago Nanomedical in New Phase with Full Focus on the Tumorad Program

October 1, 2024 5:30 AM

LUND, SWEDEN / ACCESSWIRE / October 1, 2024 / Spago Nanomedical (STO:SPAGO.ST)(FRA:7UX.F) The Board of Directors of Spago Nanomedical AB (publ) has decided that the company's resources will be focused on the development of Tumorad with the company's primary priority being the execution of the ongoing clinical study Tumorad-01 with the candidate drug 177Lu-SN201. To ensure that crucial clinical milestones can be reached and to position the...

Read more

AlzeCure's Abstract on ACD856's Anti-inflammatory Effects to be Presented at a Leading Alzheimer's Conference

October 1, 2024 4:20 AM

STOCKHOLM, SWEDEN / ACCESSWIRE / October 1, 2024 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) AlzeCure Pharma AB (publ) (FN STO:ALZCUR), a pharmaceutical company that develops candidate drugs for diseases affecting the nervous system, focusing on Alzheimer's disease and pain, today announced that an abstract with preclinical data on NeuroRestore ACD856 demonstrating its anti-inflammatory and immunomodulatory effects has been accepted for presentation...

Read more

easyXAFS Upgrades Their Service to Include a Bioz Content Hub, Enhancing Research Discovery

October 1, 2024 4:00 AM

PALO ALTO, CA / ACCESSWIRE / October 1, 2024 / Bioz, Inc., a pioneer in AI-driven citation management solutions, is excited to announce an expanded collaboration with easyXAFS, a rising star in research tools. Building on the success of their Bioz Badges, easyXAFS has upgraded to include the Bioz Content Hub on their website, taking their research engagement to the next level.Bioz Content HubBioz Content Hub on the easyXAFS Website The Bioz...

Read more